VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PROK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PROKProKidney Corp.
$1.89$268M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPROKQuarterly Cash Flow

ProKidney Corp. (PROK) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ProKidney Corp. (PROK) quarterly cash flow statement — complete operating, investing & financing history

PROK Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Cash from Operations-41.68M-32.51M-26.6M-31.42M-29.59M-24.17M-29.24M-38.29M-34.65M-25.38M-23.78M-14.92M
Operating CF Margin %-18444.25%-14450.22%-12256.22%-14215.38%-12866.09%-31803.95%------
Operating CF Growth %-40.86%-34.51%9.05%17.96%14.59%4.78%-22.98%-156.72%-33.29%-61.06%60.86%35.22%
Net Income-42.62M-40.85M-16.47M-36.97M-37.95M-48.48M-41.05M-38.47M-35.33M-21.72M-41.99M-34.82M
Depreciation & Amortization1.66M1.84M1.67M1.47M1.6M1.57M1.49M1.27M1.1M1.15M1M870K
Stock-Based Compensation4.95M5.7M06.54M6.42M6.95M6.93M7.81M7.68M-6.37M12.99M11.2M
Deferred Taxes000000000000
Other Non-Cash Items-413K42K-12.93M-566K-769K-1.76M3.66M-1.39M-2.29M-2.34M-1.68M-1.49M
Working Capital Changes-5.25M757K1.13M-1.89M1.11M17.55M-269K-7.52M-5.81M3.9M5.89M9.32M
Change in Receivables95K110K0-23K695K2.66M-2.35M-844K-529K-661K7.38M-2.61M
Change in Inventory000000000000
Change in Payables-5.96M2.16M0-2.22M-5.9M11.71M5.72M104K-5.94M3.87M-4.66M13.03M
Cash from Investing34.83M28.09M29.02M18.57M28.29M15.08M-81.64M28.57M58.4M-95.84M-28.37M-13.15M
Capital Expenditures-3.79M-5.75M-5.2M-3.11M-1.14M-25.51M-2.4M-636K-960K-1.57M-27.94M-3.7M
CapEx % of Revenue1674.78%2556.44%2394.93%1408.14%493.48%33564.47%------
Acquisitions018.21M0000000000
Investments------------
Other Investing0034.22M000000000
Cash from Financing215K17.63M7.96M-14K-12K123K4.46M139.84M-13K-9.51M-13K-13K
Debt Issued (Net)-3K-5K5K-14K-12K-14K-14K-13K-13K-13K-13K-13K
Equity Issued (Net)218K17.64M000-3K4.47M00000
Dividends Paid000000000000
Share Repurchases000000000000
Other Financing007.96M00140K0139.85M0-9.5M00
Net Change in Cash-6.64M13.21M10.38M-12.87M-1.31M-8.97M-106.42M130.12M23.74M-130.74M-52.16M-28.08M
Free Cash Flow-45.47M-38.27M-31.79M-34.53M-30.73M-49.68M-31.64M-38.93M-35.61M-26.96M-51.72M-18.62M
FCF Margin %-20119.03%-17006.67%-14651.15%-15623.53%-13359.57%-65368.42%------
FCF Growth %-47.98%22.98%-0.47%11.31%13.7%-84.3%38.81%-109.12%-31.98%-67.77%16.97%20.49%
FCF per Share-0.32-0.28-0.24-0.26-0.24-0.39-0.25-0.51-0.58-0.45-0.84-0.29
FCF Conversion (FCF/Net Income)1.85x1.69x1.61x1.90x1.77x1.14x1.63x3.06x3.65x4.45x2.16x1.64x
Interest Paid000000000000
Taxes Paid000000000000